Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04396795 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.
A Phase 2 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
NCT04396795 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 61 participants.
The verdict
NCT04396795, a Phase 2 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate changes in vascular parameters and International Index of Erectile Function (IIEF) scores with the administration of Platelet Rich Plasma (PRP) to participants with Erectile Dysfunction (ED)
Interventions
- DRUG Autologous Platelet Rich Plasma
- OTHER Saline solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-05-21 |
| Est. Completion | 2023-04-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04396795
The ClinicalTrials.gov registry entry for NCT04396795 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Autologous Platelet Rich Plasma is the first listed.
NCT04396795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04396795 about?
NCT04396795 is a clinical study titled "Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.". The purpose of this study is to evaluate changes in vascular parameters and International Index of Erectile Function (IIEF) scores with the administration of Platelet Rich Plasma (PRP) to participants with Erectile Dysfunction (ED)
What is the current status of trial NCT04396795?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2020-05-21. Estimated completion is 2023-04-18.
What interventions are being tested in trial NCT04396795?
The interventions under investigation include: Autologous Platelet Rich Plasma (DRUG), Saline solution (OTHER).
Who is sponsoring clinical trial NCT04396795?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.